1 |
Delpon E, Valenzuela C, Gay P, Franqueza L, Snyders DJ, Tamargo J. Block of human cardiac Kv1.5 channels by loratadine: voltage-, time- and use-dependent block at concentrations above therapeutic levels. Cardiovasc Res 35: 341-350, 1997
DOI
ScienceOn
|
2 |
Haller H, Spies K, Lindschau C, Quass P, Distler A. The effect of cyclosporine on calcium, protein kinase C, and sodium-proton exchange in platelets. Transplantation 57: 1516-1520, 1994
DOI
PUBMED
|
3 |
Matsuda S, Koyasu S. Mechanisms of action of cyclosporine. Immunopharmacology 47: 119-125, 2000
DOI
ScienceOn
|
4 |
Niederberger W, Lemaire M, Maurer G, Nussbaumer K, Wagner O. Distribution and binding of cyclosporine in blood and tissues. Transplant Proc 15: 2419-2412, 1983
|
5 |
Shiraishi S, Yanagita T, Kobayashi H, Uezono Y, Yokoo H, Minami SI, Takasaki M, Wada A. Up-regulation of cell surface sodium channels by cyclosporin A, FK506, and rapamycin in adrenal chromaffin cells. J Pharmacol Exp Ther 297: 657-665, 2001
PUBMED
|
6 |
Valenzuela C, Delpon E, Franqueza L, Gay P, Snyders DJ, Tamargo J. Effects of ropivacaine on a potassium channel (hKv1.5) cloned from human ventricle. Anesthesiology 86: 718-728, 1997.
DOI
ScienceOn
|
7 |
Williams CP, Hu N, Shen W, Mashburn AB, Murray KT. Modulation of the human Kv1.5 channel by protein kinase C activation: role of the Kvbeta1.2 subunit. J Pharmacol Exp Ther 302: 545- 550, 2002
DOI
ScienceOn
|
8 |
Onuma H, Lu YF, Tomizawa K, Moriwaki A, Tokuda M, Hatase O, Matsui H. A calcineurin inhibitor, FK506, blocks voltagegated calcium channel-dependent LTP in the hippocampus. Neurosci Res 30: 313-319, 1998
DOI
ScienceOn
|
9 |
Swanson R, Marshall J, Smith JS, Williams JB, Boyle MB, Folander K, Luneau CJ, Antanavage J, Oliva C, Buhrow SA, et al. Cloning and expression of cDNA and genomic clones encoding three delayed rectifier potassium channels in rat brain. Neuron 4: 929-939, 1990
DOI
ScienceOn
|
10 |
Choi BH, Choi JS, Rhie DJ, Yoon SH, Min DS, Jo YH, Kim MS, Hahn SJ. Direct inhibition of the cloned Kv1.5 channel by AG-1478, a tyrosine kinase inhibitor. Am J Physiol Cell Physiol 282: C1461-C1468, 2002
DOI
PUBMED
|
11 |
Mason HS, Latten MJ, Godoy LD, Horowitz B, Kenyon JL. Modulation of Kv1.5 currents by protein kinase A, tyrosine kinase, and protein tyrosine phosphatase requires an intact cytoskeleton. Mol Pharmacol 61: 285-293, 2002
DOI
ScienceOn
|
12 |
Choi BH, Choi JS, Jeong SW, Hahn SJ, Yoon SH, Jo YH, Kim MS. Direct block by bisindolylmaleimide of rat Kv1.5 expressed in Chinese hamster ovary cells. J Pharmacol Exp Ther 293: 634- 640, 2000
PUBMED
|
13 |
Chung I, Schlichter LC. Regulation of native Kv1.3 channels by cAMP-dependent protein phosphorylation. Am J Physiol 273: C622-C633, 1997
DOI
|
14 |
Demeule M, Giroux S, Murphy GF, Beliveau R. Cyclosporin treatment alters protein phosphorylation in kidney membranes. Biochem Cell Biol 72: 143-151, 1994.
DOI
ScienceOn
|
15 |
Steiner JP, Dawson TM, Fotuhi M, Glatt CE, Snowman AM, Cohen N, Snyder SH. High brain densities of the immunophilin FKBP colocalized with calcineurin. Nature 358: 584-587, 1992
DOI
ScienceOn
|
16 |
Wong M, Yamada KA. Cyclosporine induces epileptiform activity in an in vitro seizure model. Epilepsia 41: 271-276, 2000
DOI
ScienceOn
|
17 |
Snyders DJ, Yeola SW. Determinants of antiarrhythmic drug action. Electrostatic and hydrophobic components of block of the human cardiac hKv1.5 channel. Circ Res 77: 575-583, 1995
DOI
PUBMED
ScienceOn
|
18 |
Damjanovich S, Aszalos A, Mulhern SA, Szollosi J, Balazs M, Tron L, Fulwyler MJ. Cyclosporin depolarizes human lymphocytes: earliest observed effect on cell metabolism. Eur J Immunol 17: 763-768, 1987.
DOI
ScienceOn
|
19 |
Panyi G, Gaspar R, Krasznai Z, ter Horst JJ, Ameloot M, Aszalos A, Steels P, Damjanovich S. Immunosuppressors inhibit voltagegated potassium channels in human peripheral blood lymphocytes. Biochem Biophys Res Commun 221: 254-258, 1996
DOI
ScienceOn
|
20 |
Steiner JP, Dawson TM, Fotuhi M, Snyder SH. Immunophilin regulation of neurotransmitter release. Mol Med 2: 325-333, 1996
PUBMED
|
21 |
Tauboll E, Gerdts R, Gjerstad L. Cyclosporin A and brain excitability studied in vitro. Epilepsia 39: 687-691, 1998.
DOI
ScienceOn
|
22 |
Choi JS, Choi BH, Ahn HS, Kim MJ, Rhie DJ, Yoon SH, Min DS, Jo YH, Kim MS, Sung KW, Hahn SJ. Mechanism of block by fluoxetine of 5-hydroxytryptamine3 (5-HT3)-mediated currents in NCB-20 neuroblastoma cells. Biochem Pharmacol 66: 2125- 2132, 2003
DOI
ScienceOn
|
23 |
Choi JS, Soderlund DM. Cyclosporin A and deltamethrin block the downregulation of Nav1.8 sodium channels expressed in Xenopus oocytes. Neurosci Lett 367: 389-393, 2004
DOI
ScienceOn
|
24 |
Sigal NH, Dumont FJ. Cyclosporin A, FK-506, and rapamycin: pharmacologic probes of lymphocyte signal transduction. Annu Rev Immunol 10: 519-560, 1992
DOI
PUBMED
ScienceOn
|
25 |
Tordai A, Or R, Gelfand EW. Effects of changes in membrane potential on the cyclosporin-induced inhibition of T-cell proliferation. Biochem Biophys Res Commun 185: 363-369, 1992
DOI
ScienceOn
|
26 |
Tseng-Crank JC, Tseng GN, Schwartz A, Tanouye MA. Molecular cloning and functional expression of a potassium channel cDNA isolated from a rat cardiac library. FEBS Lett 268: 63-68, 1990
DOI
ScienceOn
|
27 |
Chen H, Kubo Y, Hoshi T, Heinemann SH. Cyclosporin A selectively reduces the functional expression of Kir2.1 potassium channels in Xenopus oocytes. FEBS Lett 422: 307-310, 1998
DOI
ScienceOn
|
28 |
Choi JS, Hahn SJ, Rhie DJ, Yoon SH, Jo YH, Kim MS. Mechanism of fluoxetine block of cloned voltage-activated potassium channel Kv1.3. J Pharmacol Exp Ther 291: 1-6, 1999
PUBMED
|
29 |
Yakel JL. Calcineurin regulation of synaptic function: from ion channels to transmitter release and gene transcription. Trends Pharmacol Sci 18: 124-134, 1997
DOI
PUBMED
ScienceOn
|